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ABSTRACT
Objectives: As the use of functioning outcomes is increasingly being
advocated in multinational clinical trials and comparative studies, making
available instruments with known validity and reliability in several lan-
guages is required. Here we present data on the Portuguese validation of the
Functioning Assessment Short Test (FAST), which was explicitly designed
to gauge functioning dimensions empirically linked to bipolar disorder.
Methods: One hundred patients with bipolar disorder and matched
controls were assessed with the FAST, which was evaluated regarding
discriminant, content and construct validity, concurrent validity with
functioning instruments, internal consistency and test–retest reliability.
Results: The FAST displayed a ﬁve-factor structure very similar to its
conceptualization, successfully discriminated patient and control groups,
and correlated highly with other functioning measures; it also showed
excellent test–retest reliability and internal consistency.
Conclusions: The FAST is a measure with sufﬁcient validity and reliability,
with potential for the use in international clinical trials and comparative
studies.
Keywords: bipolar disorder, disability, functioning, rehabilitation,
validation.
Introduction
Commonly misconceived as a relatively treatment responsive
condition with a favorable prognosis, bipolar disorder (BD) is
severe, persistent, and affects major areas of patients’ life and
functioning, often resulting in dire disability and dependency
[1,2]. Even using a conservative lifetime prevalence estimate of
around 1%, BD is the sixth leading cause of disability among
all medical disorders in market societies worldwide [3]. In
population-based studies, people with BD are consistently more
affected by work absenteeism when compared with the general
population, other mental disorders, or major depression [4–6].
Regarding indirect costs of disability in the United States alone,
it is projected that each year 96.2 million workdays and $14.1
billion salary equivalents are lost because of BD [7]. As a sub-
stantial upward revision of the 1% prevalence ﬁgure is occurring,
total disease burden is likely to be even higher.
Measuring disability in mood disorders, however, is more
complex than estimating loss of workdays or productivity. As
much as measuring functioning with simple outcomes such as
absenteeism is obviously relevant, it does not permit a richer
characterization of disability associated with mood disorders [8];
important domains of functioning may be left out, such as cog-
nition, interpersonal relationships, and autonomy [1]. The most
frequently used interviewer administered functioning measures
are global rating scales—such as the Global Assessment of Func-
tioning (GAF) Scale—which notoriously fail to distinguish clini-
cal and functional recovery [8]. Also, questionnaires based on
self-report may be problematic as results may be distorted by the
patient’s current mood [9]. Partially because of the scarcity of
adequate methods for measuring disability, only a few studies
have evaluated functioning in BD. Because data on functioning
have been obtained using instruments not designed for assessing
the main impairing domains in BD, studies may have yielded
inaccurate or clinically irrelevant information.
As a result, the International Society for Bipolar Disorders
has constituted a functionality committee devoted to promote
research in this area [10]. The Functioning Assessment Short Test
(FAST) was developed as a brief, international measure, designed
to be sensitive to change and capture the main areas of disability
for patients with BD [11]. The use of functional and patient-
centered outcomes is increasingly being advocated in multina-
tional clinical trials and comparative studies; making available
instruments with known validity and reliability in several lan-
guages is required [12,13]. Here we present data on the Portu-
guese version of the FAST regarding reliability and content,
construct, discriminant, and concurrent validity.
Methods
Participants
One hundred outpatients of the Bipolar Disorder Program at a
university hospital were consecutively recruited from September
to November 2006 for this validation study. Patients had a
clinical diagnosis of BD type I, type II, or BD not otherwise
speciﬁed, conﬁrmed with the Structured Clinical Interview
for Diagnostic and Statistical Manual of Mental Disorders-
Fourth Edition (SCID-I), and were further classiﬁed as euthymic
(those with scores below 8 in the Hamilton Depression Rating
Scale and in the Young Mania Rating Scale) or symptomatic.
Patients with comorbid mental retardation were excluded. One
hundred control subjects were recruited from the hospital catch-
ment area, matched for type of health service used, sex, age, and
educational level. This group was screened with the non-patient
version of the SCID to exclude current psychiatry morbidity, had
no ﬁrst-degree relatives with BD, schizophrenia, or other
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psychotic disorders. Participants gave written informed consent
before entering the study, which was approved by the local ethics
committee.
Instruments
The FAST is a 24-item interview constructed to assess areas
impaired in BD. Autonomy refers to the capacity of the patient of
doing things alone and taking his/her own decisions; occupa-
tional functioning refers to the capacity to maintain a paid job,
efﬁciency of performing tasks at work, working in the ﬁeld in
which the patient was educated and earning according to the
level of the employment position; cognitive functioning is related
to the ability to concentrate, perform simple mental calculations,
solve problems, learn new information, and remember learned
information; ﬁnancial issues involve the capacity of managing the
ﬁnances and spending in a balanced way; interpersonal relation-
ships refer to relations with friends, family, involvement in social
activities, sexual relations, and the ability to defend ideas and
opinions; leisure time refers to the capacity of performing physi-
cal activities (sport, exercise) and the enjoyment of hobbies [11].
Scores are determined by the sum of items, which range from 0
(indicating no problems) to 3 (indicating a severe limitation) in
the 15 days before assessment.
The FAST was developed by the Bipolar Disorder Program in
Barcelona to assess functional impairment focusing on the main
problems experienced by the mentally ill. After preliminary
analysis, the scale was discussed in a meeting with experts from
Spain, Brazil, and England, and several changes were made and
some items were rejected. This version of the FAST was trans-
lated into Portuguese from the original Spanish version. After
translation/back-translation, items with optimal word equiva-
lence were analyzed and discussed by three independent investi-
gators who agreed upon the ﬁnal version. The understanding of
each item was assessed in a pilot sample of 10 healthy controls
and 10 patients with BD and was found to be correctly under-
stood by interviewers and patients, thus providing content valid-
ity to the scale. A semistructured manual was developed for
uniform understanding of item scoring.
Interviewers blinded to FAST scores administered the
Sheehan Disability Scale [14] and the GAF to assess overall
functioning of participants. Test–retest reliability was checked 1
week after the original interview in 17 patients and 25 controls.
Statistical Analyses
Construct validity was assessed through factor analysis; we used
maximum likelihood with promax rotation to extract FAST
factors. The number of factors were selected both by using a
scree plot and the most parsimonious theoretical solution to the
data; items with loadings greater than 0.3 were retained. As
homogenous samples tend to have less variance concerning
common factors, and thus result in falsely low factor loadings,
we included controls to add heterogeneity to the analysis [15].
To evaluate internal consistency, Cronbach’s alpha was
employed. We used Wilcoxon’s signed-rank test to compare
patient and control group scores, and Mann–Whitney’s U for
comparisons within BD subgroups. Concurrent validity was
studied in comparison with the GAF and the Sheehan Disability
Scale using Spearman’s rho. Test–retest reliability was assessed
with intraclass correlation. All tests are two-tailed.
Results
Interviewers had no problems in completing the FAST and there
were no missing items, indicating high feasibility. Bartlett’s test
for sphericity was highly signiﬁcant (P < 0.001), indicating fac-
torability of the FAST. After rotation, a ﬁve-factor solution pro-
vided the best theoretical and most parsimonious account for the
data and was responsible for 72.11% of the total variance; items
essentially loaded in factors as theoretically intended; Cronbach’s
alpha was 0.95 for the whole scale and 0.82 or higher for the
subscales (Table 1). Test–retest agreement for total FAST scores
was excellent (r = 0.90; P < 0.001).
Patient and control groups were well matched regarding age,
sex, and level of education. Table 2 shows sociodemographic and
clinical variables of the sample. FAST median total scores were
Table 1 Item loadings and reliability of FAST factors
Item Occupational factor Interpersonal factor Autonomy factor Cognition factor Finance factor
FAST8 1.03
FAST9 0.99
FAST5 0.95
FAST7 0.94
FAST6 0.94
FAST19 0.96
FAST17 0.80
FAST20 0.76
FAST18 0.41 0.37
FAST22 0.39
FAST21 0.35
FAST24 0.31
FAST3 0.78
FAST4 0.78
FAST1 0.78
FAST2 0.67
FAST14 0.88
FAST10 0.74
FAST11 0.70
FAST13 0.69
FAST12 0.55
FAST23
FAST15 0.95
FAST16 0.86
Cronbach’s a 0.99 0.86 0.82 0.88 0.92
FAST, Functioning Assessment Short Test.
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26.5 (interquartile range 14–41) for the patient group and 3
(interquartile range 0.25–7) for the control group (Z = 8.28,
P < 0.001). FAST scores were also higher for the patient group
when only euthymic patients were selected (Z = 5.32, P < 0.001).
Differences were found for every FAST factor (P < 0.001 for all).
Total FAST scores were strongly correlated with the GAF
(rho = -0.70, P < 0.001) and somewhat less so with the Sheehan
Disability Scale regarding work (rho = 0.62; P < 0.001), social
(rho = 0.55; P < 0.001), and family life domains (rho = 0.54,
P < 0.001).
Discussion
The FAST, a brief interview designed to evaluate the impact of
mental illness on functioning, has proven to be a reliable and a
valid measure in a sample of patients with BD in a Brazilian
specialized treatment facility. The FAST was able to successfully
discriminate patients and controls and, moreover, discriminated
controls and currently euthymic patients. Furthermore, with the
exception of a leisure factor, the FAST is able to capture different
dimensions of disability associated with BD, as theoretically
designed, demonstrating both content and construct validity.
Although affective morbidity associated with BD, especially
depressive symptoms do impair functioning and autonomy [1], a
failure to achieve full functional recovery has been described even
after symptom remission [16]. This version of the FAST success-
fully demonstrates this important illness impact. In this sense,
this report not only replicates ﬁndings previously reported from
the Spanish version of the instrument [11], such as construct and
discriminant validity—and the more evidence that the instrument
is reliably measuring what it is speciﬁcally supposed to be mea-
suring the more conﬁdence one has in it—but also reinforces the
presence of BD-associated disability even in the absence of
syndromic-level morbidity. This should be taken to reinforce the
use of the FAST as an international instrument.
Being a complex construct, there is more than one way of
measuring disability associated with mental illness. Most of the
general instruments that assess functioning have important limi-
tations for the use in psychiatry, as mentioned before. One inter-
esting alternative, which has been validated in a sample of
patients with BD, is the Multidimensional Scale of Independent
Functioning (MSIF) [8]. The MSIF takes a different perspective
from the FAST, as it attempts to gauge functional roles, support
to these roles, and quality of the performance; as it does not
assess the FAST domains, the two instruments may be actually
evaluating two different and complementary aspects of function-
ing. Also, as far as we are aware of, the MSIF is not validated in
languages other than English.
One important limitation regarding both the MSIF and the
FAST validations, including the present one, is the inclusion of
only those patients seen in tertiary care centers, and hence most
severely affected by BD, as these do not represent people with
the whole spectrum of affective illness. As mentioned before,
however, adding heterogeneity to the sample generally increases
factor loadings [15]. The lack of a consensual gold standard for
measuring disability in severe mental illness is a further difﬁculty.
Consequently, criterion validity was measured as compared with
the Sheehan Disability Scale and the GAF, which are general
scales, but nonetheless of widespread use. Additionally, as an
instrument designed to detect effectiveness of treatments in func-
tional recovery, the performance of the FAST still needs to be
evaluated in an interventional setting to conﬁrm feasibility and
psychometric properties [17].
The burden of BD is large and growing, resulting in both
direct [18] and indirect costs. Rehabilitation research in BD has
been hindered by the lack of speciﬁc and valid functioning mea-
sures [10]; in treatment studies, the instrument used to quantify
functional outcomes may critically inﬂuence effectiveness esti-
mates [16]. With valid and reliable measures, interventions tar-
geted at improving functioning could minimize both the chronic
morbidity and burden associated with BD.
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